NetScientific is a life sciences & healthcare, investment technology, and commercialisation group.
We fund and develop companies that significantly improve the health and well-being of people with chronic diseases.

Our Portfolio

Targeting Life Sciences & Healthcare, Investment Technology, and Sustainability

Board and Management

Sector-specialist senior management team with extensive commercial experience.

  • John Clarkson

    John Clarkson, Non-Executive Chairman of the Group, is an experienced business professional and qualified accountant, who had a successful early career working in various financial, audit and management positions in the UK and overseas. John then completed a full time MBA at Cranfield University, before moving into management consultancy with Deloitte Haskins + Sells. There [...]
    Non-Executive Chairman
  • Dr Ilian Iliev

    Dr. Ilian Iliev, Chief Executive Officer, is Managing Director of EMV Capital, a London-based investor in B2B companies in the industrial high-tech, energy, circular economy, smart cities and transportation sectors and healthcare. EMVC’s investments in Europe, Israel and the US cover a range of technologies including robotics and AI, machine learning, materials science, IoT, advanced [...]
    Chief Executive Officer
  • Professor Stephen Smith

    Professor Stephen Smith, Non-Executive Director, joined the NetScientific Board in 2016. Stephen has held senior leadership roles in the NHS and academia. He has had a long and distinguished career as a clinician scientist, Head of Department, Dean and CEO. His name is associated with the Medical Research Council, University of Cambridge, Imperial College, London [...]
    Non-Executive Director
  • Stephen Crowe

    Stephen Crowe, CFO, A commercial, growth-focused and highly experienced Finance Leader with over 20+ years of experience in a wide range of financial institutions from blue chip organizations such as AXA to owner managed SME’s such as THB Group, R K Carvill & Co. and Towergate Partnership. A qualified chartered accountant by profession with a [...]


NetScientific plc ("NetScientific" or the "Company") PDS Biotech Announces Mount Sinai Publication of Studies Showing Superior Induction of Antibodies by Versamune®-based COVID-19 Vaccine Versamune® T-cell activating platform demonstrates breadth of anti-SARS-CoV-2 immune responses in a COVID-19 vaccine   London, UK – 21 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, [...]
NetScientific plc ("NetScientific" or the "Company") ProAxsis Limited awarded Innovate UK grant to utilise company technology to identify high risk COVID-19 patients London, UK - 10 December 2020 - NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation company, announces that its portfolio company ProAxsis Limited ("ProAxsis"), announced that it has been awarded [...]
NetScientific plc (“NetScientific”, the “Group” or the “Company”) Board changes and grant of Options   London, UK – 2 December 2020 – NetScientific plc (AIM: NSCI), the life sciences, technology, investment and commercialisation Group, is pleased to announce the planned strengthening of the Board in line with the stated strategy and shareholder circular from 6 [...]
NetScientific healthcare technology group